Related Experiment Video
Updated: Aug 8, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
BCL-2 in prostate cancer: a minireview
1Biochemistry Division, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. scatz@scripps.edu
Prostate cancer progression involves genetic changes affecting survival pathways. The pro-survival protein BCL-2 is highly expressed in advanced, androgen-independent prostate cancer, linking it to disease progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer progression and androgen independence are linked to genetic abnormalities affecting survival and apoptotic pathways.
- The pro-survival protein BCL-2 is overexpressed in advanced, androgen-independent prostate tumors.
- BCL-2 upregulation after androgen ablation in cell lines and animal models suggests a role in prostate cancer progression.
Purpose of the Study:
- To review experimental evidence linking BCL-2 expression to prostate carcinogenesis and progression.
- To analyze the connection between the phosphatidylinositol 3-kinase (PI 3-kinase)/nuclear factor kappa B (NF-kappaB) survival pathway and BCL-2 upregulation.
- To examine how hormone ablation influences this survival pathway and explore therapeutic strategies.
Main Methods:
- Literature review of experimental evidence.
- Analysis of studies on BCL-2 expression in prostate cancer.
- Examination of the PI 3-kinase/NF-kappaB pathway and its relation to BCL-2.
- Investigation of hormone ablation effects and therapeutic interventions.
Main Results:
- BCL-2 expression is associated with prostate carcinogenesis and cancer progression.
- The PI 3-kinase/NF-kappaB pathway is linked to BCL-2 upregulation.
- Hormone ablation influences this survival pathway, contributing to resistance.
Conclusions:
- BCL-2 plays a significant role in prostate cancer progression and androgen independence.
- Targeting the PI 3-kinase/NF-kappaB pathway and BCL-2 may offer therapeutic strategies.
- Understanding BCL-2's role is crucial for developing effective treatments for advanced prostate cancer.
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

